36 research outputs found
Pallium Canada's curriculum development model: A framework to support large-scale courseware development and deployment
The need to improve access to palliative care across multiple settings and disease groups has been identified. This
requires equipping health care professionals from many different professions, including physicians and nurses,
among others, with basic palliative care competencies to provide a palliative care approach. Pallium Canada’s
Curriculum Development Framework supports the development, deployment, and dissemination, on a large scale,
of multiple courses targeting health care professionals across multiple settings of care and disease groups. The
Framework is made up of eight phases: (1) Concept, (2) Decision, (3) Curriculum Planning, (4) Prototype Development, (5) Piloting, (6) Dissemination, (7) Language and Cultural Adaptation, and (8) Ongoing Maintenance
and Updates. Several of these phases include iterative cyclical activities. The framework allows multiple courses to
be developed simultaneously, staggered in a production line with each phase and their corresponding activities
requiring different levels of resources and stakeholder engagement. The framework has allowed Pallium Canada to
develop, launch, and maintain numerous versions of its Learning Essential Approaches to Palliative Care (LEAP)
courses concurrently. It leverages existing LEAP courses and curriculum materials to produce new LEAP courses,
allowing significant efficiencies and maximizing output. This article describes the framework and its various
activities, which we believe could be very useful for other jurisdictions undertaking the work of developing
education programs to spread the palliative care approach across multiple settings, specialties, and disease groups
Physics Opportunities with the 12 GeV Upgrade at Jefferson Lab
This white paper summarizes the scientific opportunities for utilization of
the upgraded 12 GeV Continuous Electron Beam Accelerator Facility (CEBAF) and
associated experimental equipment at Jefferson Lab. It is based on the 52
proposals recommended for approval by the Jefferson Lab Program Advisory
Committee.The upgraded facility will enable a new experimental program with
substantial discovery potential to address important topics in nuclear,
hadronic, and electroweak physics.Comment: 64 page
Canine models of copper toxicosis for understanding mammalian copper metabolism
Hereditary forms of copper toxicosis exist in man and dogs. In man, Wilson’s disease is the best studied disorder of copper overload, resulting from mutations in the gene coding for the copper transporter ATP7B. Forms of copper toxicosis for which no causal gene is known yet are recognized as well, often in young children. Although advances have been made in unraveling the genetic background of disorders of copper metabolism in man, many questions regarding disease mechanisms and copper homeostasis remain unanswered. Genetic studies in the Bedlington terrier, a dog breed affected with copper toxicosis, identified COMMD1, a gene that was previously unknown to be involved in copper metabolism. Besides the Bedlington terrier, a number of other dog breeds suffer from hereditary copper toxicosis and show similar phenotypes to humans with copper storage disorders. Unlike the heterogeneity of most human populations, the genetic structure within a purebred dog population is homogeneous, which is advantageous for unraveling the molecular genetics of complex diseases. This article reviews the work that has been done on the Bedlington terrier, summarizes what was learned from studies into COMMD1 function, describes hereditary copper toxicosis phenotypes in other dog breeds, and discusses the opportunities for genome-wide association studies on copper toxicosis in the dog to contribute to the understanding of mammalian copper metabolism and copper metabolism disorders in man
ATP-binding cassette (ABC) transporters in normal and pathological lung
ATP-binding cassette (ABC) transporters are a family of transmembrane proteins that can transport a wide variety of substrates across biological membranes in an energy-dependent manner. Many ABC transporters such as P-glycoprotein (P-gp), multidrug resistance-associated protein 1 (MRP1) and breast cancer resistance protein (BCRP) are highly expressed in bronchial epithelium. This review aims to give new insights in the possible functions of ABC molecules in the lung in view of their expression in different cell types. Furthermore, their role in protection against noxious compounds, e.g. air pollutants and cigarette smoke components, will be discussed as well as the (mal)function in normal and pathological lung. Several pulmonary drugs are substrates for ABC transporters and therefore, the delivery of these drugs to the site of action may be highly dependent on the presence and activity of many ABC transporters in several cell types. Three ABC transporters are known to play an important role in lung functioning. Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene can cause cystic fibrosis, and mutations in ABCA1 and ABCA3 are responsible for respectively Tangier disease and fatal surfactant deficiency. The role of altered function of ABC transporters in highly prevalent pulmonary diseases such as asthma or chronic obstructive pulmonary disease (COPD) have hardly been investigated so far. We especially focused on polymorphisms, knock-out mice models and in vitro results of pulmonary research. Insight in the function of ABC transporters in the lung may open new ways to facilitate treatment of lung diseases
Track D Social Science, Human Rights and Political Science
Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/138414/1/jia218442.pd
Pallium Canada's curriculum development model: A framework to support large-scale courseware development and deployment
The need to improve access to palliative care across multiple settings and disease groups has been identified. This
requires equipping health care professionals from many different professions, including physicians and nurses,
among others, with basic palliative care competencies to provide a palliative care approach. Pallium Canada’s
Curriculum Development Framework supports the development, deployment, and dissemination, on a large scale,
of multiple courses targeting health care professionals across multiple settings of care and disease groups. The
Framework is made up of eight phases: (1) Concept, (2) Decision, (3) Curriculum Planning, (4) Prototype Development, (5) Piloting, (6) Dissemination, (7) Language and Cultural Adaptation, and (8) Ongoing Maintenance
and Updates. Several of these phases include iterative cyclical activities. The framework allows multiple courses to
be developed simultaneously, staggered in a production line with each phase and their corresponding activities
requiring different levels of resources and stakeholder engagement. The framework has allowed Pallium Canada to
develop, launch, and maintain numerous versions of its Learning Essential Approaches to Palliative Care (LEAP)
courses concurrently. It leverages existing LEAP courses and curriculum materials to produce new LEAP courses,
allowing significant efficiencies and maximizing output. This article describes the framework and its various
activities, which we believe could be very useful for other jurisdictions undertaking the work of developing
education programs to spread the palliative care approach across multiple settings, specialties, and disease groups
Histological demonstration of immunoreactive zinc metallothionein in liver and ileum of rat and man
Thigh-length compression stockings and DVT after stroke
Controversy exists as to whether neoadjuvant chemotherapy improves survival in patients with invasive bladder cancer, despite randomised controlled trials of more than 3000 patients. We undertook a systematic review and meta-analysis to assess the effect of such treatment on survival in patients with this disease